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Regulation of NF-jB Activity and Keratinocyte
Differentiation by the RIP4 Protein: Implications
for Cutaneous Wound Repair
Stephanie Adams1, Sandra Pankow2, Sabine Werner2 and Barbara Munz1
Receptor-interacting proteins (RIPs) are important regulators of cell proliferation and differentiation. As RIP4 is a
crucial modulator of epidermal differentiation, we analyzed the expression of different rip genes in healing skin
wounds. Rip4 expression was strongly downregulated in keratinocytes of the hyperproliferative epithelium at
the wound edge early after injury and only returned to basal levels after completion of wound repair. Rip3
expression was strongly induced as early as 1 day after wounding. In contrast, rip and rip2 expression remained
unaltered. To determine the factors that regulate rip4 gene expression in keratinocytes, human HaCaT
keratinocytes were used as a model system. We found that scratch wounding as well as treatment with whole
serum, phorbol esters, the growth/differentiation factors epidermal growth factor, transforming growth factor-b,
and activin A, or the proinflammatory cytokines tumor necrosis factor-a and IL-1b strongly suppressed rip4
expression in these cells. In contrast, the steroid dexamethasone and all-trans retinoic acid slightly stimulated
rip4 expression. Suppression of rip4 expression in keratinocytes using small interfering RNA technology
reduced the activation of NF-kB, and enhanced the expression of epidermal differentiation markers in these
cells. These data suggest important and unique functions of different RIP proteins in keratinocytes of normal
and wounded skin.
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INTRODUCTION
Receptor-interacting proteins (RIPs) associate with the in-
tracellular domain of members of the tumor necrosis factor
receptor (TNFR) family of proteins and mediate downstream
signalling, in particular the activation of NF-kB and the
induction of apoptosis (Dempsey et al., 2003; Gaur and
Aggarwal, 2003).
To date, five different RIP proteins have been described.
RIP, RIP2, RIP3, and RIP4 share a highly homologous amino-
terminal serine-threonine kinase domain, but their carboxy
termini differ. Whereas RIP contains a death domain (Stanger
et al., 1995) and RIP2 (RICK, CARDIAK) harbors a CARD,
both of which can induce apoptosis (Inohara et al., 1998;
McCarthy et al., 1998; Thome et al., 1998), the carboxy-
terminal domain of RIP3 has no homology to known proteins
(Padzernik et al., 1999; Sun et al., 1999; Yu et al., 1999).
The carboxy terminus of RIP4 (DIK, PKK) contains an
ankyrin-repeat domain (Ba¨hr et al., 2000; Chen et al.,
2001; Holland et al., 2002; Meylan et al., 2002). RIP5 is
unique in a way that this recently identified member of the
RIP family is characterized by a carboxy-terminal RIP-specific
kinase domain (Zha et al., 2004). In all RIPs, the amino- and
carboxy-terminal domains are linked via an intermediate
domain, which is specific for each of the five proteins.
Based on the phenotypic abnormalities of RIP-, RIP2-,
RIP3-, and RIP4-deficient mice (Kelliher et al., 1998; Chin
et al., 2002; Kobayashi et al., 2002; Holland et al., 2002;
Newton et al., 2004), RIP4 appears to be the most important
RIP protein in epidermal keratinocytes. RIP4-deficient mice,
which die shortly after birth most likely from suffocation
owing to oral fusion, are characterized by multiple skin
defects. In particular, these animals show a hyperthickened
epidermis with hyperplasia of the spinous and granular
layers. In contrast, the outermost cornified layers are absent
and are replaced by a thick layer of flattened, parakeratotic
cells. Labelling studies with 5-bromo-20-deoxyuridine
showed that the increased epidermal thickness observed in
these mice is not due to enhanced keratinocyte proliferation.
However, an abnormal expression pattern of various early
and late differentiation markers could be observed in the
RIP4-deficient animals (Holland et al., 2002).
These data suggest that RIP4 is an important modulator of
epidermal growth and differentiation. As a tight regulation of
these processes is important in cutaneous wound repair
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(reviewed by Martin, 1997), we hypothesized that RIP4 might
also be an important regulator of this process. Here, we show
that expression of the rip4 gene is strongly downregulated
early after skin injury and in cultured keratinocytes stimulated
with different growth factors and cytokines. Furthermore, we
demonstrate that inhibition of rip4 expression in keratino-
cytes modulates the differentiation pattern of these cells,
indicating that RIP4 might also be an important regulator of
re-epithelialization after injury.
RESULTS
RIP4 expression is strongly downregulated after skin injury
To study the regulation of the rip4 gene in wound healing, we
analyzed its expression in murine excisional wounds via
Northern blot. As shown in Figure 1a, expression of the rip4
gene was strongly downregulated as early as 1 hour after
wounding, and was hardly detectable after 6 hours. Rip4
messenger RNA levels subsequently increased again, but
remained reduced compared to non-wounded skin until the
wound was fully healed (day 14 after injury). In contrast to
rip4, expression of the rip and rip2 genes was unaltered after
wounding (data not shown). Interestingly, expression of the
rip3 gene was induced after injury, reaching maximal levels
during the early inflammatory phase of healing (24 hours – 3
day after injury) (Figure 1a). To analyze if differential
expression in wound healing is a common feature of TNFR-
associated proteins, we also analyzed expression of TNFR-
associated protein 6 (TRAF6), a ubiquitously expressed
signalling intermediate that associates with various members
of the TNFR superfamily. We found that expression of traf6
was not regulated as early as rip4, but was downregulated at
later stages of the repair process and did not return to basal
levels within 14 days after wounding (Figure 1b).
When we analyzed RIP4 localization in wound tissue by
immunofluorescence, we found strong expression in the
intact epidermis and in hair follicle keratinocytes adjacent to
the wound, but only very faint staining within the hyperpro-
liferative epithelium at the wound edge (Figure 1d). In
contrast, rip3 expression was absent or weak in epidermal
keratinocytes, but prominent in some dermal cells which
might be immune cells (Figure 1c). No staining was seen with
the respective secondary antibodies only (data not shown).
These data suggest that TNFR-associated proteins have
unique and distinct functions in wound healing and that
differential expression of the respective genes does not simply
reflect an overall regulation of the activity of signalling cascades
downstream of members of the TNFR family of receptors.
Rip4 expression is repressed by growth factors and cytokines in
cultured keratinocytes
In addition to our results, previous in vivo data (Holland
et al., 2002) suggest that RIP4 is the most important RIP
protein in the epidermis. Therefore, the strong downregula-
tion early after injury may be of functional importance for the
epidermal repair process. To determine possible reasons for
the strong downregulation of rip4 expression in wounded
skin, we studied the regulation of rip4 gene expression in
cultured keratinocytes. For this purpose, the immortalized,
but non-tumorigenic HaCaT keratinocyte cell line (Boukamp
et al., 1988) was used. Cells were wounded by scratching and
then analyzed for differential expression of the rip4 gene. As
shown in Figure 2a, rip4 expression was strongly down-
regulated after scratching, suggesting that regulation of this
gene occurs at least in part by a cell-autonomous mechanism.
To gain insight into the factors, which might be responsible
for the regulation of rip4 gene expression after wounding,
HaCaT keratinocytes were serum-starved for 16 hours and
then stimulated with whole serum or different growth factors
and cytokines. As shown in Figure 2b–g, rip4 expression was
strongly downregulated by serum, EGF, transforming growth
factor-b, activin A, TNF alpha, or IL-1b. As a broad variety of
growth factors and cytokines can modulate activation of the
protein kinase C pathway, we also analyzed the effect of the
phorbol ester phorbol 12-myristate 13-acetate on rip4
expression. As shown in Figure 2h, this compound also
strongly suppressed rip4 expression in keratinocytes, suggest-
ing a role of the protein kinase C pathway in the regulation of
the rip4 gene. Interestingly, treatment with the steroid
dexamethasone, which has been shown to inhibit keratino-
cyte proliferation (Zendegui et al., 1988; Florin-Christensen
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Figure 1. Expression of rip genes in healing skin wounds. (a, b) Expression of
the rip3, rip4, and traf6 genes was studied by Northern blot analysis. For each
lane, equal amounts of total RNA (5 mg) isolated from normal or wounded skin
were used. Staining of the 28S and 18S rRNAs using methylene blue served as
a loading control as indicated. (c, d) Localization of RIP3 and RIP4 protein in
wounded skin was studied by immunofluorescence using specific antibodies.
The left wound edge of a full-thickness excisional wound including the
hyperproliferative epithelium is shown. The schematic drawings (top panels)
indicate the localization of the left wound edge within the wound. Note the
strong RIP3 signal in some dermal cells within the granulation tissue below
the wound and at the wound edge and the strong RIP4 signal in normal
epidermis at a distance from the wound. Less RIP4 was found in the
keratinocytes of the hyperproliferative epithelium at the wound edge
(D: dermis, E: epidermis, G: granulation tissue, HE: hyperproliferative
epithelium, HF: hair follicle). Bar¼50 mm.
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Figure 2. Regulation of rip4 expression in cultured keratinocytes. Expression of the rip4 gene was studied in cultured keratinocytes by Northern blot. For each lane,
equal amounts of total RNA (1–8mg) were used. Representative results are shown. Staining of the 28S and 18S rRNAs using methylene blue served as a loading control as
indicated. (a) The cells were either scratch wounded and harvested at the indicated time points, or treated with the following agents: (b) serum, (c) EGF, (d) transforming
growth factor-b, (e) Activin A, (f) TNF alpha, (g) IL-1b, (h) phorbol 12-myristate 13-acetate, (i) dexamethasone, and (j) all-trans retinoic acid. (k) Quantification of the
results shown in (a–j).
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et al., 1992), had a slight stimulatory effect on rip4 expression
(Figure 2i). Similarly, treatment with all-trans retinoic acid,
which can have differential effects on keratinocyte growth
and differentiation depending on the context (reviewed by
Fisher et al., 1995; Fisher and Voorhees, 1996), induced rip4
gene expression (Figure 2j). These data suggest that specific
serum-derived growth factors and cytokines downregulate
rip4 expression in keratinocytes. In contrast, glucocorticoids
and vitamin A derivates can induce expression of this gene.
Inhibition of rip4 expression in cultured keratinocytes leads to
decreased NF-jB activation in these cells and enhances
keratinocyte differentiation
To analyze the function of RIP4 in keratinocytes, HaCaT cells
were treated with specific small interfering RNA (siRNAs)
directed against the RIP4 messenger RNA. As shown in Figure
3a, this treatment indeed reduced RIP4 messenger RNA levels
by 80% when compared to untreated cells. As RIP4 is an
activator of NF-kB, we analyzed activation of this transcrip-
tion factor in our RIP4 siRNA-treated cells. For this purpose,
we assayed expression levels of the NF-kB inhibitor protein
IkBa by Western blot: When NF-kB becomes activated, it
dissociates from IkB, which results in destabilization and
eventually degradation of the latter (Moynagh, 2005). Thus,
IkB levels can be inversely correlated with the extent of
NF-kB activation in the cell. As shown in Figure 3b, we
found that our siRNA-treated cells were characterized
by higher levels of IkBa when compared to controls,
suggesting that downregulation of rip4 expression leads to
decreased NF-kB activation in these cells. When we
analyzed the effect of RIP4 siRNAs on keratinocyte prolifera-
tion, we did not observe significant alterations in the cell
proliferation rate within 20 hours after siRNA transfection
(data not shown). To study possible effects of RIP4 on
keratinocyte differentiation, we also analyzed expression of
epidermal differentiation markers in our siRNA-treated cells.
As shown in Figure 3c, we detected higher expression levels
of the epidermal differentiation marker keratin 10 in the cells
that had been treated with the RIP4-specific siRNAs. A similar
effect was seen when we analyzed expression of the
involucrin gene (data not shown). These data suggest that
downregulation of rip4 expression as observed after wound-
ing affects the balance between keratinocyte proliferation
and differentiation.
DISCUSSION
Here, we provide first evidence for a role of RIP4 in wound
repair. Expression of the rip4 gene was strongly down-
regulated within a few hours after injury and remained low
during the whole repair process. When analyzing the spatial
expression pattern of RIP4 in normal skin and in wound
tissue, we found high levels of RIP4 protein in the
keratinocytes of the intact epidermis. This is consistent with
the in vivo studies published by Holland et al. (2002), which
demonstrated that RIP4 is particularly important in tissues
composed of keratinized stratified epithelial cells. Interest-
ingly, RIP4 expression was lower in the keratinocytes of the
hyperproliferative wound epithelium compared to keratino-
cytes of the non-injured skin adjacent to the wound and
hardly detectable in the dermal compartment. Thus, the
strong reduction in rip4 messenger RNA levels observed after
wounding appears to be owing to downregulation of this
gene in keratinocytes. Therefore, the regulation of rip4
expression and the consequences of its suppression were
studied in cultured keratinocytes.
To gain insight into the nature of the factors that might be
responsible for the downregulation of rip4 expression in
keratinocytes in response to wounding, we carried out a
series of in vitro experiments. As after injury, serum growth
factors and cytokines are released from injured vessels, in
particular from degranulating platelets (Werner and Grose,
2003, and references therein), we speculated that these
factors might control rip4 expression. Thus, we analyzed rip4
expression in cultured HaCaT keratinocytes after stimulation
with serum or with different purified growth factors and
cytokines. Interestingly, we found that whole serum as well as
the growth factors EGF and transforming growth factor-b1,
strongly downregulated rip4 gene expression in these cells.
A similar effect was observed with the proinflammatory
cytokines IL-1b and TNF alpha, which are highly expressed in
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Figure 3. Inhibition of rip4 gene expression via siRNA technology.
(a) Decreased rip4 messenger RNA levels after treatment with specific
si-RNA preparations. HaCaT keratinocytes were treated with specific siRNA
preparations and a random control. They were analyzed for rip4 gene
expression by Northern blotting 8 hours and 44 hours after the transfection
procedure was completed as indicated. Staining of the 28S and 18S rRNAs
using methylene blue served as a loading control as indicated. (b) Decreased
activation of NF-kB after treatment with RIP4-specific siRNAs. Western blot
analysis of IkBa expression in RIP4-siRNA treated HaCaT cells and controls
(untreated, treated with transfection reagent only, or treated with an
unspecific ‘‘scrambled’’ siRNA) 24 hours after completion of the transfection
procedure. Incubation with an actin-specific antibody served as a loading
control as indicated. Note the high levels of IkBa in the cells that had been
treated with the RIP4-specific siRNAs, indicating low NF–kB activity in these
cells. (c) Increased expression of differentiation markers after treatment with
RIP4-specific siRNAs. Western blot analysis of keratin 10 expression in
RIP4-siRNA-treated HaCaT cells and controls 24 hours after completion of
the transfection procedure. Incubation with an actin-specific antibody served
as a loading control as indicated. Note the high levels of keratin 10 protein
in the cells that had been treated with RIP4-specific siRNA preparations.
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inflammatory cells within the first few days after injury
(Hu¨bner et al., 1996). These results indicate that serum
growth factors and cytokines might control RIP4 down-
regulation in keratinocytes in response to injury.
RIP4 has been shown to be an activator of NF-kB when
overexpressed in vitro (Meylan et al., 2002; Cariappa et al.,
2003; Moran et al., 2003). Consistently, using siRNA
technology to inhibit rip4 expression, we found enhanced IkB
levels, indicating decreased NF-kB activation in HaCaT cells.
These results strongly suggest that RIP4 is an activator of
NF-kB in keratinocytes. Indeed, the phenotype of rip4/
mice in part resembles that of mice lacking IKKa, a
component of the complex that regulates NF-kB (Holland
et al., 2002). However, skin grafting experiments by the same
group could demonstrate that in addition to its possible
function as an NF-kB activator, RIP4 also has a cell-
autonomous function in keratinocytes, which is independent
of the NF-kB pathway. In addition, it will be crucial to study
regulation of NF-kB signalling by the RIP4 protein in primary
human keratinocytes, especially from the background that
immortalized keratinocytes, such as HaCaT cells, are
characterized by abnormal NF-kB signalling in various
experimental settings (Chaturvedi et al., 1999, 2001;
Qin et al., 1999; Muller et al., 2003; Lewis et al., 2006;
Ren et al., 2006). Furthermore, in future, it will be interesting
to identify other signalling pathways that are controlled by
RIP4 in normal and wounded skin. As several reports
revealed that in addition to its NF-kB-activating function,
RIP4 is also a modulator of the protein kinase C signalling
pathway in certain cell types and has therefore been
described earlier as DIK or PKK (Ba¨hr et al., 2000; Chen
et al., 2001), it is possible that the modulation of protein
kinase C-associated signalling is also an important function of
RIP4 in keratinocytes.
Finally, using siRNA technology to inhibit RIP4 expres-
sion, we found that reduction in the levels of RIP4 in
keratinocytes stimulated expression of the epidermal differ-
entiation markers K10 and involucrin, but had no effect on
the rate of keratinocyte proliferation in vitro. Furthermore,
preliminary results from our laboratory suggest that keratino-
cytes that had been treated with RIP4-specific siRNAs are
characterized by higher levels of the hyperproliferation-
associated keratin 16. In contrast, inhibition of rip4 gene
expression appears to have little or no effect on the
expression of the proliferation-associated keratin 14 gene in
our experimental settings (our unpublished results). The
proliferation results are consistent with the in vivo data
described by Holland et al. (2002), who could not detect an
abnormal keratinocyte proliferation rate in rip4-deficient
mice. Rather, they suggested that the increased epidermal
thickness seen in rip4 (/) mice is primarily due to an
abnormal pattern of keratinocyte differentiation.
The kinetics of rip4 downregulation very early after skin
injury and its downregulation after scratch wounding suggests
that this protein might be a regulator of keratinocyte migration.
Interestingly, several reports demonstrate that the growth factor
EGF, which can induce downregulation of rip4 expression in
HaCaT cells (this study), also stimulates keratinocyte migration
in vitro and in vivo (Nickoloff et al., 1988; Ando and Jensen,
1993; Chen et al., 1993). Furthermore, the cytokine TNF
alpha, which also suppresses rip4 expression in HaCaT cells
(our data), had a positive effect on keratinocyte migration in
vitro and in vivo in healing wounds (Scott et al., 2004). Thus, it
is possible that rip4, as a target gene of these factors, is
important for proper keratinocyte migration in a healing
wound, thereby modulating re-epithelialization.
At later stages after wounding, the reduced levels of RIP4
may also be important for the induction of keratinocyte re-
differentiation as suggested by the enhanced expression of
differentiation markers upon reduction of RIP4 levels in
cultured keratinocytes. This differentiation-inducing effect
may be counteracted in early wounds by the high levels of
mitogens present at the wound site.
In future, it will be interesting to analyze whether RIP4
downregulation is necessary for normal healing. For this
purpose, the generation of transgenic mice which over-
express the rip4 gene in the epidermis will be necessary.
These experiments should provide further insight into the
function of the RIP4 protein in skin repair.
MATERIALS AND METHODS
Wounding and preparation of wound tissue
Four full-thickness excisional wounds of 0.5 cm diameter were
generated on the back of female Balb/c mice (10–12-week old) by
dissecting skin and panniculus carnosus as described (Werner et al.,
1994). The wounds were left untreated. Mice were killed at different
time points after injury. Complete wounds including 2 mm of the
epidermal margins were excised. For gene expression studies,
wounds from five or more mice were pooled for each individual
time point investigated. Experiments were performed with at least
two independent sets of pooled RNAs for each time point. Non-
wounded skin served as a negative control. All experiments with
animals were performed with permission from the local veterinary
authorities, Zurich, Switzerland.
Immunofluorescence
For immunofluorescence analysis, complete wounds including
2–3 mm of adjacent back skin were isolated, bisected, fixed in 1%
acetic acid/95% ethanol, embedded in paraffin, and cut at 6 mm
thickness. For detection of the endogenous RIP4 protein, depar-
affinized sections of paraffin-embedded tissues were incubated in
blocking buffer and subsequently in blocking buffer containing the
first antibody overnight at 41C (mouse polyclonal anti-RIP4 (Abnova,
Heidelberg, Germany). Bound antibody was detected with an
FITC-conjugated anti-mouse IgG antibody (Dianova, Hamburg,
Germany), and sections were mounted in 10% glycerol after a final
washing step. They were analyzed using an Axioscope fluorescence
microscope (Zeiss, Jena, Germany).
Tissue culture
Human HaCaT keratinocytes were cultured in DMEM containing
10% fetal bovine serum. For treatment with growth factors and
cytokines, cells were serum-starved for 16 hours. They were then
treated with the following agents: phorbol 12-myristate 13-acetate
(100 nM), fetal bovine serum (10%), EGF (20 ng/ml), transforming
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growth factor-b (1 ng/ml), activin A (5 ng/ml), TNF alpha (Roche,
Mannheim, Germany, 1 ng/ml), IL-1b (100 U/ml), dexamethasone
(1mM), and retinoic acid (1mM).
Scratch wounding
Confluent HaCaT monolayers were serum-starved for 24 hours. They
were then scratched with a plastic pipette tip to yield wounds with a
uniform width.
siRNA technology
HaCaT keratinocytes (2 105) were trypsinized, resuspended in
normal growth medium, and transfected in suspension with 100 nM
(final concentration) of two different siRNAs specific for the human
rip4 gene (Ambion, Austin, TX) or a random (scrambled) control
siRNA according to the instructions of the manufacturer. They were
then seeded in six-well plates and incubated at 371C overnight. The
next morning, the medium was either replaced by fresh growth
medium or cells were incubated in serum-free medium for another
4–36 hours. Subsequently, total cellular RNA or protein was isolated
from the cells.
RNA isolation
Total cellular RNA was extracted with the RNeasy RNA isolation kit
(Qiagen, Hilden, Gemany) and poly(A) RNA was isolated by using
oligo(dT) cellulose spin columns (Clontech, Mountain View, CA)
according to the instructions of the manufacturer.
Northern blot analysis
One to eight micrograms of total RNA isolated as described
above was separated on a 1% agarose gel containing formaldehyde
(2%). Subsequently, RNA was transferred to a nylon membrane.
Filters were hybridized overnight with antisense riboprobes,
which had been labelled with the digoxigenin RNA labelling kit
(Roche). After washing, blots were incubated with an alkaline
phosphatase-coupled antidigoxigenin antibody (Roche), washed,
and developed with CDP-Star (Tropix, Bedford, MA or Roche) as
a chemiluminescent substrate for alkaline phosphatase. Signals
were detected via exposure to X-ray films (ranging from 2 seconds
to 5 minutes).
Preparation of protein lysates and Western blot analysis
Cultured cells were lysed in lysis buffer (1% Triton X-100, 20 mM
Tris-HCl (pH 8.0), 137 mM NaCl, 10% glycerol, and 2 mM EDTA (pH
8.0)). Ten micrograms of total protein was loaded on a SDS-
polyacrylamide gel and transferred to nitrocellulose membranes.
Membranes were pre-blocked in 3% powdered milk in Tris-buffered
saline containing 0.5% Tween-20 for 30 minutes; incubated with a
dilution of the first antibody in blocking solution for 1 hour, washed
three times with Tris-buffered saline containing 0.5% Tween-20;
incubated for 30 minutes with a 1:2.500 dilution of the second
antibody, a peroxidase-conjugated anti-mouse, or anti-rabbit mAb
(Amersham, Little Chalfont, UK) in blocking solution; washed three
times with Tris-buffered saline containing 0.5% Tween-20; and
developed with the enhanced chemiluminescence Western blot
detection system (Amersham).
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